News

Kempbio provides bioservices to the biotechnology and biopharmaceutical industry. Polyplus-transfection said that by signing this license, Kempbio becomes one of its sub-licensees for the use of PEI technology

Under the five-year agreement, Pfizer will provide $22.5m to Washington University and give its scientists access to research data on a large array of Pfizer pharmaceutical candidates that

Kemwell has increased its production capacity by expanding the production area from 16,000 to 31,000 square meters. The expansion not only makes it possible for the company to

The data demonstrated positive therapeutic activity in the prevention of serious lung infection in mechanically ventilated patients colonised with the bacterium and in limiting potentially damaging inflammation in

As per the terms of the agreement, KemPharm will be responsible for drug product, preclinical and clinical studies, along with regulatory filings, while Johnson Matthey will be responsible

Cerenis Therapeutics said that results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for

Dr Mansour has spent nearly 25 years in the life sciences industry with positions at Biochem Pharma and Wyeth Pharmaceuticals. His most recent position at Wyeth Research was

Forest Labs and Nycomed claimed that if approved, roflumilast, a once-a-day oral tablet, will be the first in a new class of treatment for COPD. Roflumilast is not

The patents are the most recent of 13 international and US patents to issue to the University of Michigan for breast cancer diagnostic and therapeutic uses of Mammastatin.